Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices 48065

control of nuisance plant species

(Phragmites australis), increasing the

availability of fresh water, improving

internal water quality, and protecting

and restoring beach and freshwater

wetlands habitat.

3. Scoping

a. Numerous studies and reports

addressing beach erosion along the New

Jersey Coast were conducted by the

Corps of Engineers. The most recent

study for this area is a Reconnaissance

Report; Lower Cape May Meadows—

Cape May Point Reconnaissance Study

(August 1994), which identified a

number of problem areas where erosion

and tidal inundation were negatively

impacting the shoreline and adjacent

wildlife habitat. This study identified

Lower Cape May Meadows and Cape

May Point as areas to be recommended

for further study in the feasibility phase.

b. The scoping process is on-going

and has involved preliminary

coordination with Federal, State, and

local agencies. Participation of the

general public and other interested

parties and organizations will be invited

by means of a public notice.

c. The significant issues and concerns

that have been identified include the

impacts of the project on aquatic biota,

water quality, intertidal habitat, shallow

water habitat, migratory bird species,

and cultural resources.

4. Availability

It is estimated that the DEIS will be

made available to the public in

November 1997.

Gregory D. Showalter,

Army Federal Register Liaison Officer.

[FR Doc. 97–24199 Filed 9–11–97; 8:45 am]

BILLING CODE 3710–GR–M

DEPARTMENT OF ENERGY

Office of Environment, Safety and

Health; Notice of Availability of Funds

and Request for Applications To

Deliver Special Medical Care in the

Marshall Islands

AGENCY: Office of Environment, Safety

and Health, Department of Energy.

ACTION: Request for applications.

SUMMARY: The Department of Energy

(DOE) Office of Environment, Safety and

Health (EH) is requesting applications to

provide special medical care to a

specific group of citizens of the

Republic of the Marshall Islands (RMI).

This Notice of Availability of Funds and

Request for Applications to Deliver

Special Medical Care in the Marshall

Islands is a follow-on to a more general,

annual notice of potential availability of

grants and cooperative agreements for

epidemiology and other health studies

published in the Federal Register on

October 16, 1996.

DATES: The deadline for receipt of

applications is October 27, 1997.

ADDRESSES: Applications may be

submitted to Mr. Neil Barss at the U.S.

Department of Energy, Office of

International Health Programs, EH–63/

270CC, 19901 Germantown Road,

Germantown, Maryland 20874–1290.

FOR FURTHER INFORMATION CONTACT:

Requests for application forms, the

additional program information

described below, and any other requests

for information in response to this

Notice should be directed to Mr. Barss,

U.S. Department of Energy, Office of

International Health Programs, EH–63/

270CC, 19901 Germantown Road,

Germantown, Maryland 20874–1290;

telephone: (301) 903–4024; facsimile:

(301) 903–1413; or email:

neil.barss@eh.doe.gov.

SUPPLEMENTARY INFORMATION:

Table of Contents

I. Introduction

II. Purpose

III. Background

IV. Program Requirements

V. Applications

VI. Application Format and Instructions

VII. Application Review, Evaluation Criteria

and Award Information

VIII. DOE’s Role

IX. Applicants

I. Introduction

A Draft Notice of Availability of

Funds and Request for Applications for

the Department of Energy Medical

Program in the Republic of the Marshall

Islands was published in the Federal

Register on May 29, 1997 (62 FR 29125).

A public meeting was held July 8, 1997

to receive comments and questions on

the Draft Notice. A Notice of Potential

Applicant Visit to Honolulu, Hawaii,

and the Republic of the Marshall Islands

was published in the Federal Register

on September 5, 1997 (62 FR 46954). In

addition, the following information will

be made available in conjunction with

the application forms:

(1) A transcript of the public meeting;

(2) Answers to questions of general

interest raised at and submitted in

written form after the public meeting;

(3) The ‘‘Memorandum Of

Understanding Between The U.S. Army

Space And Strategic Defense Command

(USASSDC) U.S. Army Kwajalein Atoll/

Kwajalein Missile Range (USAKA/KMR)

And The U.S. Department of Energy

Office Of International Health

Programs’’;

(4) A tabulation of DOE medical

equipment used currently by

Brookhaven National Laboratory and

associated location and functional

status;

(5) Marshall Islands Medical Program

reports provided to the U.S. Congress by

DOE for the last five years;

(6) A table illustrating distribution of

DOE’s Marshall Islands program budget

for FY 1990 through FY 1997, which

includes the DOE’s special medical care

program;

(7) A list of predominant diseases

observed in DOE patients by

Brookhaven National Laboratory and the

ICD–9 code associated with each

disease;

(8) The forms required by the Office

of International Health Programs for

budget planning, program progress and

activity reporting, in addition to those

specified in 10 CFR part 600; and

(9) A report entitled, ‘‘Medical Status

of Marshallese Accidentally Exposed to

1954 Bravo Fallout Radiation: January

1988 through December 1991’’, DOE/

EH–0493 and BNL–52470, July 1995.

As noted above, DOE has arranged a

site visit to Honolulu and the Republic

of the Marshall Islands for potential

applicants. Anyone who intends to

participate in the site visit and has not

contacted Mr. William Jackson for

details and arrangements should do so

immediately. Mr. Jackson can be

reached by telephone at (808) 422–9211

or 422–9203, by facsimile at (808) 422–

9217, or by e-mail at

bjackson@tis.eh.doe.gov.

II. Purpose

DOE provides a special medical care

program for a specific group of RMI

citizens in accordance with section

103(h) of the Compact of Free

Association Act of 1985, as amended,

which mandates that the United States

‘‘shall continue to provide special

medical care and logistical support

thereto for the remaining * * *

members of the population of Rongelap

and Utrik [sic] who were exposed to

radiation resulting from the 1954 United

States thermonuclear ‘Bravo’ test,

pursuant to Public Laws 95–134 and

96–205.’’ Section 104(a)(4) of Public

Law 95–134, enacted in 1977, directed

the Secretary of the Interior to provide

for the populations residing on

Rongelap and Utirik Atolls on March 1,

1954, ‘‘adequate medical care and

treatment * * * of any radiation injury

or illness directly related to the

[’’Bravo’’] thermonuclear detonation

* * *’’ Section 104(a)(4) goes on to state

that, ‘‘The costs of such medical care

and treatment shall be assumed by the

Administrator of the Energy Research
48066 Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices

and Development Administration,’’ a

precursor agency to DOE. Pursuant to

this congressional mandate, DOE

provides a special medical care program

consisting of:

• Medical screening, diagnosis and

treatment for radiation-related diseases

or illnesses (see Appendix A for

definition) in an economically

disadvantaged tropical environment in

the central Pacific.

• Medical care and treatment of other

diseases or illnesses as time and

resources permit.

• Administrative management,

cognizance and oversight of patients

and patient records, clinical referrals

and followups as medically appropriate.

DOE is soliciting applications to

provide medically appropriate care to

the exposed population and a

comparison group within applicable

legal, financial and logistical

constraints. By so doing, DOE is seeking

ways to more effectively and efficiently

deliver special medical care services in

the Marshall Islands to an aging

population. As used in this Notice,

primary medical care means the

community based medical services

provided locally at each Atoll by

medically trained individuals.

Secondary medical care means those

medical services provided at the U.S.

Army Hospital at Kwajalein Atoll or by

other providers, as described below.

Tertiary medical care means medical

services that are not currently available

in the Marshall Islands and that must be

provided to the patients outside the

Marshall Islands.

Subject to available funding, DOE

intends to award one (1) cooperative

agreement in support of the RMI special

medical care program in FY 1998. The

cooperative agreement award will be for

a one (1) year budget period, and subject

to available funding, may be negotiated

and extended annually as continuation

awards for up to four (4) additional

years.

The funding level for the

implementation of the current DOE

primary and secondary special medical

care program is $1.1 million annually.

III. Background

As a result of the 1954 United States’

thermonuclear ‘‘Bravo’’ test in the

Marshall Islands, approximately 253

Marshallese people (hereinafter referred

to as patients) on Rongelap and Utirik

Atolls were exposed to high levels of

radioactive fallout. Since 1956, DOE and

its predecessor agencies have provided

medical care to these patients. Within

DOE, this special medical care program

is currently administered by the Office

of International Health Programs for the

Assistant Secretary for Environment,

Safety and Health.

Currently, there are three programs

providing medical care in the RMI:

• The RMI Ministry of Health

national medical care program for

approximately 60,000 people.

This care is delivered at primary and

secondary care facilities on Ebeye and

Majuro islands, with smaller facilities in

the remote outer islands that function as

first aid stations, providing limited

primary care and pharmaceutical

capabilities (see Appendix B for details).

Two-way radio is the primary means of

inter-atoll communications, and

medical emergencies are transported by

air from the outer islands to Ebeye or

Majuro.

• The 177 Health Care Program (177

HCP), described in section 103(j) of the

Compact of Free Association Act of

1985 as the Four Atoll Health Care

Program.

This program provides medical care

for the people of the Atolls of Bikini,

Enewetak, Rongelap, and Utirik who

were affected by the consequences of

the 1946–1958 U.S. nuclear testing

program in the northern Marshall

Islands, and their descendants. The

program is administratively overseen by

the Department of the Interior (DOI), is

funded by the U.S. Congress through the

DOI, and is currently implemented by

Mercy International, Inc., under contract

to the RMI Ministry of Health. The

program serves approximately 10,600

individuals (see Appendix C for

additional details) and provides primary

medical care, secondary care referrals to

the hospitals at Ebeye and Majuro, and

tertiary care referrals to the Queen’s

Medical Center and Group in Honolulu,

Hawaii.

Since 1986, DOE patients have been

referred to the 177 HCP for primary and

continued medical care during the time

between Brookhaven National

Laboratory screening visits and for nonradiation related disease or injuries.

Currently, the 177 HCP has not been

able to adequately meet all the medical

needs of the DOE patients.

• The special medical care program

provided by DOE to approximately 238

patients in the Rongelap and Utirik

communities.

DOE’s special medical care program

currently provides biannual medical

screening visits and full medical care for

radiation-related conditions for the

remaining 131 members of the original

patient population, as well as medical

treatment for approximately 107 people

in a comparison group. From the

inception of DOE’s program, medical

treatment has been delivered biannually

by teams consisting of Brookhaven

National Laboratory (BNL) employees

supplemented with volunteer medical

specialists. Logistical support for DOE’s

special medical care program has also

been provided by a contractor, which is

currently Bechtel Nevada Corporation.

In 1995, DOE transitioned from

biannual vessel-based medical missions

to biannual land-based medical

missions located at Kwajalein Island.

Vessel-based missions were

handicapped by the inability to keep a

vessel equipped with state-of-the-art

medical equipment. The land-based

approach has improved the quality of

medical care delivery for the patient

populations in Rongelap and Utirik and

will also effect cost efficiencies. This

approach makes available at the U.S.

Army Hospital on Kwajalein Island in

the Marshall Islands secondary medical

care facilities and more sophisticated

diagnostic equipment and improved

laboratory capabilities, for example: use

of ultrasound equipment; ability to

perform immediate fine needle

aspiration or thyroid surgery;

availability of certified mammography

equipment and other medical

equipment that permits immediate

followup, additional tests, and surgery

when needed.

As with vessel-based care, the landbased system includes visits to infirm

patients in their homes at Mejatto and

Utirik. Land-based medical assets have

also added the ability to provide full

diagnostics and tests of samples taken

right after the visit to these remote

islands, rather than (as previously)

shipping such samples for analysis to

the U.S. mainland.

Those DOE patients with medical

conditions that can be effectively

managed in the Marshall Islands are

either treated by the BNL medical

personnel at the U.S. Army hospital on

Kwajalein Island or are referred to the

177 HCP. Those DOE patients with

radiation-related medical findings that

cannot be managed in the Marshall

Islands are referred to Straub Hospital

and Clinic in Honolulu for tertiary

evaluation and medical treatment.

In January 1997, the RMI requested

the DOE to compete the current special

medical care program due to problems

being experienced by the 177 HCP and

the RMI’s desire to have more of the

allocated budget spent on medical care

services rather than on logistical

support services.

IV. Program Requirements

A. General

Note: The terms ‘‘application’’ and

‘‘proposal’’ are used synonymously herein.
Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices 48067

(1) The awardee will be required to

execute a special medical care program

within DOE requirements and budget;

provide continuity with the medical

program conducted since 1956; and

operate in a highly visible international

political environment and under

rigorous oversight by the U.S. Congress.

(2) A Primary Application (see

definition in section VI. A., herein) shall

describe the applicant’s approach to the

primary and secondary clinical medical

elements, as well as the other elements

of the special medical care program

identified in section IV.B. herein, based

on a budget of $1.1 million annually

over a 5-year period. In preparing

applications to deliver DOE’s special

medical care program in the RMI,

potential applicants should consider

innovative ways to:

(a) Provide full-time medical services

in the Marshall Islands to the Rongelap

and Utirik communities, sufficient to

cover the medical needs of the affected

Marshallese citizens.

(b) Collaborate and coordinate

medical care delivery with local

Marshallese health care providers.

(c) Use telemedicine and other

electronic technologies that enhance

professional communications and

maximize cost savings.

(d) Use recruited volunteer medical

professionals to maximize cost savings.

(e) Provide medical services as much

as possible within the Marshall Islands,

thus reducing the need for expensive

tertiary medical referrals.

(f) Use current DOE contractor,

subcontractor and interagency support

(i.e., Bechtel Nevada Corporation, the

Straub Hospital and Clinic, and the U.S.

Army Hospital at Kwajalein; see

Appendices D, E, and F, respectively,

for currently provided services).

(3) In addition, the applicant may

submit an Optional Application (see

definition in section VI.A., herein) for

an alternative approach to replace a part

or all of the following being provided by

current DOE providers:

(a) Tertiary medical care services for

an annual average of 13 patients, and/

or

(b) Related logistical support for an

annual average of 13 patients receiving

tertiary medical care services, and/or

(c) Related logistical support for the

primary and secondary medical care

services of all the DOE patients within

the Marshall Islands. Such an

application should be based on an

annual budget that does not exceed

$800,000.

For example, in FY 1996, DOE spent

$259,000 on 13 patient referrals to the

Straub Hospital and Clinic. For each

patient, this cost involved both the

medical services provided at the Straub

Hospital and Clinic and the concomitant

logistical services provided by Bechtel

Nevada Corporation. Examples of

patient logistical support costs include,

as a minimum, the following:

• Patient travel costs to and from his/

her local atoll to Majuro Atoll;

• Patient travel costs to and from

Majuro Atoll to the tertiary care facility

located outside the RMI (currently

Straub Hospital and Clinic);

• Patient travel costs to and from

Kwajalein Atoll for the medical services

currently provided at the U.S. Army

Hospital;

• Marshallese translator salaries and

travel costs and/or patient family

member escort travel costs; and

• Associated lodging, meal, and

living expenses incurred for all

individuals while the patient is in

transit or being treated at any location.

B. Project Description

For the approximately 238 patients,

whose general medical and

demographic information is

summarized in Appendix G, the

awardee shall either itself implement or

use subcontractors for the following

special medical care program

requirements:

The DOE Clinical Medical Program

For this program element:

(a) Conduct and implement a primary,

secondary and tertiary clinical medical

program for patients with radiationrelated diseases and illnesses in a

tropical and under-developed area of

the world, together with the treatment of

as much non radiation-related disease as

medically indicated and as resources

permit. The clinical medical program

should be implemented by primary care

medical professional(s) augmented by

physicians with specialties including,

but not limited to oncology, diagnostic

radiology, gynecology, internal

medicine, and endocrinology, as

appropriate.

(b) Provide the services of other

medical specialists, as indicated by

patient condition, including but not

limited to the fields of: allergy/

immunology, cardiology, dentistry,

dermatology, emergency medicine,

family practice, gastroenterology,

geriatrics, hematology, infectious

diseases and parasitology, nephrology,

neurology, nuclear medicine, obstetrics,

ophthalmology, pathology, physical

medicine, pulmonary medicine,

rheumatology, surgery, tropical

medicine and therapeutic radiology.

(c) Provide, in addition to the

physician services specified in this

section, nursing, pharmacy, radiology

(including nuclear medicine), clinical

laboratory, histology and pathology,

inpatient, outpatient and technical

medical support services.

(d) Institute appropriate ethical

safeguards to ensure patient informed

consent in writing.

(e) Provide appropriate gender

medical personnel to accommodate

Marshallese cultural sensitivities.

(f) Conduct medical examinations in

accordance with medical screening

recommendations, published guidelines

or standards (e.g., American Cancer

Society, American College of

Physicians, U.S. Preventive Services

Task Force of the Department of Health

and Human Services, etc.).

(g) Provide radiology services that

include:

(1) Mammography utilizing a unit that

is certified by the American College of

Radiology and complies with U.S. Food

and Drug Administration regulations.

(2) Diagnostic equipment that has

been inspected for radiological safety

and approved for operation (e.g., chest

x-ray, nuclear medicine imaging or

therapy, mammography).

(3) Therapy as clinically prescribed

for the treatment of cancer.

(h) Conduct examinations of the

thyroid gland including:

(1) Thyroid ultrasound measurements.

(2) Palpation of the thyroid by a

physician skilled in such technique.

(3) Appropriate blood and chemistry

tests of thyroid function (e.g., TSH, T3,

T4).

(i) Provide diagnostic and clinical

laboratory services, as appropriate.

(j) Utilize laboratory testing

capabilities and services that comply

with the requirements specified in the

Clinical Laboratory Improvement

Amendments of 1988 (documentation

required).

(k) Provide appropriate

immunizations, as indicated by patient

needs.

(l) Provide pharmaceuticals, medical

supplies or equipment based on the

needs of the patients.

(m) Provide pathological services for

the identification of cancer.

Administrative Support

For this program element:

(a) Obtain insurance (and

documentation thereof) for medical

malpractice and comprehensive general

liability, for $1 million per occurrence

and $3 million aggregate for each

insurance type for any U.S. licensed

individual.

(b) Implement non-medical

administrative functions in support of

the special medical care program, which

shall at a minimum include the

following:
48068 Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices

(1) Provision of non-medical

personnel and administrative staff

services to adequately support the

medical personnel and services.

(2) If the awardee intends to use

DOE’s contractors or the services of the

U.S. Army Hospital at Kwajalein, the

awardee will be required to:

(i) Establish and maintain a working

programmatic relationship with Bechtel

Nevada Corporation.

(ii) Establish and maintain a working

programmatic relationship with the

current secondary or tertiary referral

facilities (U.S. Army Hospital at

Kwajalein and Straub Hospital and

Clinic in Honolulu). These services are

currently provided pursuant to a

Memorandum of Understanding

between DOE and the U.S. Army Space

and Strategic Defense Command at

Kwajalein Atoll and a subcontract

between Bechtel Nevada Corporation

and Straub Hospital and Clinic,

respectively.

(3) As applicable, establish and

maintain a working programmatic

relationship with existing medical

providers in the Marshall Islands and/

or the 177 HCP (using the capabilities

listed in Appendix C), to help

implement the DOE special medical

care program.

(4) Provide current state-of-the-art

methods for the consolidation, storage,

management and retention of current

and historical patient medical records

and medical program operational

records, which will include receipt of

approximately 30 cubic feet of all

hardcopy medical records, a similar

volume of records compressed onto

compact discs and an Oracle 

database of current patients.

(5) Protect the confidentiality of

patient medical information and

records.

(6) Implement a continuing quality

control and assurance program for all

clinical medical and recordkeeping

aspects of the program necessary to

maintain compliance with applicable

medical standards.

(7) Develop and implement a

transition phase with Brookhaven

National Laboratory.

Direct Marshallese Involvement

For this program element:

(a) Interface, establish and maintain a

working relationship with Marshallese

appointed spokespersons and/or citizen

advisory committees in the Rongelap

and Utirik communities to:

(1) Consult and inform before

implementing any changes in the DOE

special medical care program.

(2) Establish a regular process that

receives community and patient input

and feedback on DOE special medical

care program activities.

(3) Consider Marshallese patient

concerns and recommended

improvements in the special medical

care delivery;

(4) Work with DOE to accommodate

Marshallese concerns and

improvements within a framework of

DOE’s legal mandate, funding and

sound medical practice.

(b) Develop and implement a

Rongelap and Utirik community health

outreach educational program that:

(1) Develops educational materials

(e.g., videotapes, brochures and/or

handouts) that include DOE and

Marshallese community representative

input, to be used by health care

providers that strive to accentuate

awareness of, increase sensitivity to,

and accommodate Marshallese

traditional perceptions and attitudes

towards the practice of ‘‘Western-style’’

medicine in the Marshall Islands.

(2) Helps patients and their family

members learn about the special

medical care program activities and

findings by preparing, distributing and

explaining the annual medical activity

report, which is required to be sent to

DOE.

(3) Utilizes Marshallese public health

educational materials and brochures.

(4) Develops public health and

educational materials (e.g., handouts,

brochures or videotapes) for Marshallese

use that describes the types of special

medical care being provided by the

awardee.

(5) Advises on the known

relationships between radiation dose

and health effects.

(c) Develop and implement a training

program for Marshallese medical and

para-medical, and/or technical support

professionals for the special medical

care program that includes:

(1) A needs assessment as to the types

and number of professionals

(physicians, physician assistants,

nurses, support-service technicians).

(2) Means to provide training and

‘‘on-the-job’’ practical experience in the

Marshall Islands.

(3) Consideration of available regional

educational resources to meet these

objectives.

(d) Develop and implement a plan to

build an infrastructure in the Marshall

Islands for the special medical care

program including:

(1) Partnerships with local health care

providers.

(2) Facilitating the training of

Marshallese health care professionals.

(3) Acquisition, use, and maintenance

of medical equipment.

Development of Procedures and

Documentation

The awardee will be required to

provide the following:

(a) Written protocol(s) and/or manuals

describing procedures and associated

forms to be used by the medical

professionals for medical examinations,

patient referrals, and overall

administrative implementation of the

special medical care program that

includes:

(1) Identities, qualifications, and

biographies of medical or medical

program experience for all persons

providing medical, technical, nursing,

and administrative support services.

(2) The awardee’s selection and

qualification criteria for all personnel

who will participate in or implement

the program.

(3) Involvement of local Marshallese

medical, health, and support personnel,

including:

(i) Participation of medical and other

health care or technical professionals.

(ii) As applicable, selection and

qualification criteria by which these

personnel will be made eligible to

participate.

(iii) Provision of bilingual

Marshallese/English speaking

individuals for adequate

communication, translation and the

interpretation of examination results,

and meaning between the patients (or

their designated guardians) and the

medical care providers.

(4) Frequency and types of patient

examinations.

(5) Method(s) of patient examinations

and treatments that afford personal

privacy.

(6) Method(s) by which patient

informed consent and medical release

will be obtained for any medical

examination or treatment modality in a

way that ensures patient understanding

in Marshallese.

(7) As applicable, method(s) by which

a special medical care program

physician will interface with existing

medical care providers in the Republic

of the Marshall Islands or the Pacific

region and provide tertiary medical

referrals as needed.

(8) Method(s) by which medical

services will be provided to those

patients (currently, approximately 25)

who habitually reside in the United

States, such as other medical care

insurance options in lieu of awardee

provided medical services.

(9) Method(s) by which the program

referring physician will consult with

and remain continually cognizant of the

medical condition and results of a

patient referred to another medical
Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices 48069

professional or organization identified

in items (7) or (8).

(10) Method(s) to inform all patients

(or their designated guardians) in

Marshallese of individual medical

results and any additional followup

actions necessary.

(11) Method(s) by which

pharmaceuticals will be obtained,

inventoried, managed, and dispensed.

(12) Method(s) for retaining, storing,

maintaining, or releasing (to honor a

lawful request), patient tissue samples

and specimens used for pathological

classification of disease.

(13) As applicable, method(s) by

which the awardee will implement the

working programmatic relationships

with any current DOE provider of

services or regional health care

provider.

(b) An annual summary report (in

English and Marshallese) on the

following:

(1) Program activities, medical

conditions, and statistical analyses of

the findings.

(2) Number of individuals remaining

in the patient and comparison

populations.

(3) The overall health of the two

populations and the identification of

any special risks to their health.

(4) Identification of all medical,

nursing, technical practitioners, and

support personnel that performed

provider services.

(5) Identification of patient related

medical problems with

recommendations for improvement or

resolution.

(6) Progress made on strategic plan

initiatives.

(7) Recommendations to improve

programmatic functions.

(c) A strategic plan that proposes and

details ways to advance the special

medical care program to:

(1) Achieve partnership and

coordination with the RMI medical and

health care organizations.

(2) Evolve medical partnerships and

coordinate the awardee’s resources, to

the greatest extent possible, with local

Marshallese or other U.S. Federal

resources, to advance the DOE’s special

medical care program as follows:

(i) Strengthen local health care

delivery.

(ii) Involve local personnel in medical

activities.

(iii) Share new skills and technical

knowledge.

(iv) Strengthen local land-based

assets, such as radiologic, pathologic,

and laboratory support services.

(3) Maintain a cost effective special

medical care program as the patient

population ages and incurs greater

needs for medical services.

Cost and Reporting Requirements

(a) The awardee shall implement cost

containment measures, maximization of

financial savings, and negotiation of

subcontracted services to maintain a

high quality special medical care

program in accordance with DOE

budgetary constraints. At a minimum,

the cost reporting requirements that will

be required under the cooperative

agreement will include, but not be

limited to providing:

(1) Budget, financial and

programmatic activity reports. The

contents and formats are to be specified

and revised as necessary by DOE.

(2) A monthly report of all program

expenditures.

(3) Fiscal planning and budget

information in the format prescribed by

DOE.

(4) A separate itemized price list

(detailing both direct and indirect costs)

for all clinical medical examinations,

treatments, services, or supplies to

conduct and implement the special

medical care program.

(5) A separate itemized price list for

the direct and indirect medical program

and non-clinical administrative and

program management aspects, salaries,

and supplies for the proposed support

services.

(6) A separate itemized price list for

any service that is anticipated to be

subcontracted.

(7) A separate itemized price list for

any capital equipment that must be

purchased to implement the special

medical care program.

(8) The formula or estimated cost for

each of the following non-priced listed

items:

(i) Special DOE requests (e.g., record

duplication, statistical analysis of

medical findings, special topical reports

in response to RMI or congressional

inquiries).

(ii) Non-stocked medical or

administrative items and supplies.

(iii) Cost of any other service or

expense that the provider intends to

charge but does not appear on a price

list.

V. Applications

This Notice of Availability of Funds

and Request for Applications is issued

pursuant to DOE regulations contained

in 10 CFR part 602: Epidemiology and

Other Health Studies Financial

Assistance Program, as published in the

Federal Register on January 31, 1995

(60 FR 5841). The Catalog of Federal

Domestic Assistance number for 10 CFR

part 602 is 81.108, and its solicitation

control number is EOHSFAP 10 CFR

part 602. 10 CFR 602 contains the

specific requirements for applications,

evaluation, and selection criteria, except

as modified herein. Only those

applications complying with the criteria

and using the forms specified in 10 CFR

602 will be considered. Application

forms may be obtained at the address

previously cited. Applications will be

peer reviewed by evaluators apart from

DOE employees and contractors as

described under section 10 CFR 602.9(c)

and in section VII. of this Notice, and

submission of an application constitutes

agreement that this is acceptable to the

care provider(s) and the submitting

organization.

VI. Application Format and

Instructions

A. General

An application shall contain a

proposal for the following:

• The primary and secondary clinical

medical program;

• The other elements of the special

medical care program (i.e.,

administrative support, direct

Marshallese involvement, the

development of procedures and

documentation, the cost and reporting

elements);

• Any proposed replacement for part

or all of the secondary medical services

provided at the U.S. Army Hospital on

Kwajalein Island in the Kwajalein Atoll.

For the purposes of this Notice, the

proposal containing the above

components will be referred to as the

Primary Application and shall contain

two volumes, one providing technical

details and the other the costs.

In addition, an Optional Application

may be submitted for an alternative

approach to replace a part or all of the

following being provided by current

DOE providers:

• Tertiary medical care services for an

annual average of 13 patients, and/or

• Related logistical support for an

annual average of 13 patients receiving

tertiary medical care services, and/or

• Related logistical support for the

primary and secondary medical care

services of all the DOE patients within

the Marshall Islands.

The Optional Application shall also

contain two volumes, one for the

technical details and the other for the

cost. The technical volumes for both the

Primary and Optional Applications

shall be:

• No more than one hundred (100)

pages in length;

• One-sided, 12-point font size; and

• Submitted in black and white.

Resumes of key personnel should be

submitted as an appendix to the

technical application(s) and will not be
48070 Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices

counted against the page limit. Cost

proposal volume(s) have no page limit

and either one or both application(s)

will be structured to include a five (5)

year project period consisting of five

one (1) year budget periods.

The application(s) shall not merely

offer to perform work in accordance

with the program requirements but shall

outline the actual work proposed as

specifically as possible.

B. Specific Application Instructions

All applicants must submit a Primary

Application for the special medical care

program, as described herein, based on

a budget of $1.1 million annually over

a 5 year period. An Optional

Application for an alternative approach

as described herein may also be

submitted, based on a budget that does

not exceed $0.8 million annually over a

5-year period. If an Optional

Application is not submitted, the DOE

will assume that the applicant plans to

utilize the current DOE provider

logistical support, and the secondary

and tertiary medical care services

referenced herein. However, an

applicant can propose in the Primary

Application any replacement for the

secondary medical services currently

provided at the U.S.Army Hospital at

Kwajalein Island (see paragraph (1)(n),

as follows).

(1) The technical volume of the

Primary Application must include

technical details and information that:

(a) Demonstrate that the applicant has

the experience and capability to plan,

organize, implement, and manage the

primary and secondary medical care

services and all the other elements of

the special medical care program

described herein. This includes

organizational structure, plans for selfassessment of the special medical care

program, and envisioned relationship

with DOE.

(b) Demonstrate the competency of

the applicant’s personnel and the

adequacy of its resources.

(c) Identify technical and

administrative staff, and detail their

professional experience, as well as their

level of program involvement. In the

event that any of the proposed

personnel are not currently employed

by the applicant, letters of commitment

from those individuals shall be

submitted.

(d) Itemize the medical diagnostic or

laboratory equipment that the applicant

intends to use for this special medical

care program, and how the applicant

will integrate such equipment with the

Federal Government owned equipment

listed in Appendix H.

(e) Specify the location(s) where

services will be obtained or performed.

(f) Identify the recommendations or

standards to be used to satisfy the

requirements of section IV.B., paragraph

(f) under the special medical care

program element, DOE Clinical Medical

Program, and any reason for

exception(s) taken by the applicant to

those standards.

(g) Contain initial concepts for the

training program development

requirements of paragraph (c) under the

special medical care program element,

Direct Marshallese Involvement.

(h) Contain initial concepts for the

development and implementation of the

applicant’s plan to meet the Marshall

Islands infrastructure requirements of

paragraph (d) under the special medical

care program element, Direct

Marshallese Involvement.

(i) Contain a short-term plan detailing

milestones and deadlines stating:

(i) Applicant’s requirements for a

transition phase with Brookhaven

National Laboratory.

(ii) When independence will be

achieved to implement all elements of

the special medical care program.

(j) Contain initial concepts for the

strategic plan required by paragraph (c)

under the special medical care program

element, Development of Procedures

and Documentation, that includes

milestones and deadlines for

implementation.

(k) Provide evidence of medical

malpractice insurance for any

individual licensed in the United States,

required by paragraph (a) under the

Administrative Support element of the

special medical care program.

(l) Provide applicant’s plan to obtain

malpractice insurance for any non-U.S.

health care provider that the applicant

intends to hire or provide.

(m) Propose a plan to provide medical

care services and associated logistical

support for those Marshallese patients

who do not habitually reside in the

Marshall Islands.

(n) Identify and propose, if the

applicant desires, a replacement for any

or all of the secondary medical care

services provided at the U.S. Army

Hospital on Kwajalein Island.

(2) The cost volume of the Primary

Application must include the following

information that:

(a) Provides a cost proposal for the

first budget period year (year 1)

detailing expenses to implement the

following:

(i) The primary and secondary

medical services of the DOE Clinical

Medical program element of the special

medical care program;

(ii) The Administrative Support

element of the special medical care

program;

(iii) The Direct Marshallese

Involvement element of the special

medical care program;

(iv) The Development of Procedures

and Documentation element of the

special medical care program;

(v) Establishment and maintenance of

a working relationship with DOE

providers of medical and logistics

services;

(vi) The medical care services, in

combination with associated logistical

support, for those Marshallese patients

who do not habitually reside in the

Marshall Islands;

(vii) The costs to replace any or all of

the secondary medical services

currently provided at the U.S. Army

Hospital on Kwajalein Island; and

(viii) The identification and

magnitude of any other cost the

applicant intends to charge.

(b) Contains estimated cost

information supporting the applicant’s

special medical care project description

for budget years 2 through 5.

(3) If an Optional Application is

submitted, the applicant shall

demonstrate its approach to replacing

the logistical support for the primary

and secondary clinical medical program

in the Marshall Islands, and/or the

approach to replacing the tertiary

medical care for an annual average of 13

patients currently provided by Straub

Hospital and Clinic, as specified in

Appendix E, and/or the logistical

support of such tertiary medical care for

the annual average of 13 patients. The

technical volume of the Optional

Application must include the following

information that:

(a) Demonstrates that the applicant

has the experience and capability to

plan, organize, implement, and manage

the tertiary medical care services and

logistical support requirements. This

includes organizational structure, plans

for self-assessment of the special

medical care program, and envisioned

relationship with DOE.

(b) Demonstrates the competency of

the applicant’s personnel and the

adequacy of its resources.

(c) Identifies technical and

administrative staff, and details their

professional experience, as well as their

level of program involvement. In the

event that any of the proposed

personnel are not currently employed

by the applicant, letters of commitment

from those individuals shall be

submitted.

(d) Itemizes the medical diagnostic or

laboratory equipment that the applicant

intends to use for tertiary medical care
Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices 48071

services, and how the applicant will

integrate such equipment with the

Federal Government owned equipment

listed in Appendix H.

(e) Specifies the location(s) where

tertiary medical care services will be

obtained or provided. The applicant is

free to propose tertiary referral locations

of its choosing within or outside of the

Marshall Islands.

(f) Identifies the standards to be used

to satisfy the requirements of section

IV.B., paragraph (f) under the special

medical care program element, DOE

Clinical Medical Program, and any

reason for exception(s) taken by the

applicant to those standards.

(g) If applicable, contains initial

concepts for any tertiary medical care

training program development

requirements of paragraph (c) under the

special medical care element, Direct

Marshallese Involvement. This also

includes any proposal to use local

Marshallese individuals or companies to

perform logistical support requirements.

(h) Contains initial concepts for the

development and implementation of the

applicant’s plan to meet the

infrastructure requirements of paragraph

(d) under the special medical care

element, Direct Marshallese

Involvement.

(i) Contains a short-term plan

detailing milestones and deadlines

stating:

(i) If applicable, applicant’s

requirements for a transition phase with

Straub Hospital and Clinic and Bechtel

Nevada Corporation,

(ii) When independence will be

achieved to implement all elements of

the tertiary medical care services and

the associated logistical requirements.

(j) Contains initial concepts for the

strategic plan required by paragraph (c)

under the special medical care program

element, Development of Procedures

and Documentation, that includes

milestones and deadlines for long-term

implementation of any proposals to

replace the tertiary medical and

associated logistical support services.

(k) Provides evidence of medical

malpractice insurance for any

individual licensed in the United States,

required by paragraph (a) under the

Administrative Support element of the

special medical care program.

(l) Provides applicant’s plan to obtain

malpractice insurance for any non-U.S.

health care provider that the applicant

intends to hire or provide.

(4) The cost volume of the Optional

Application must include the following

information that:

(a) Provides a cost proposal for the

first budget period year (year 1)

detailing expenses to implement the

following:

(i) Tertiary medical care services for

an annual average of 13 patients, and/

or

(ii) Logistic support for an annual

average of 13 patients receiving tertiary

medical care services, and/or

(iii) Logistic support for the primary

and secondary medical services of all

the DOE patients provided in the

Marshall Islands.

(iv) The identification and magnitude

of any other tertiary medical service or

logistical support cost the applicant

intends to charge.

(b) Contains estimated cost

information supporting the applicant’s

special medical care program project

description for budget years 2 through 5.

VII. Application Review, Evaluation

Criteria and Award Information

Primary Applications will be subject

to merit review (peer review) and will

be evaluated against the following

criteria, all of which are of equal

importance. The peer review will be

conducted by the Division of Research

Grants (DRG) of the National Institutes

of Health (NIH), utilizing standard NIH

peer review procedures. The following

criteria constitute a single case

deviation from the Office of

Environment, Safety and Health’s merit

review system (57 FR 55524, November

25, 1992) and EH’s program rule at 10

CFR 602.

(a) The medical and technical merit of

the proposed special medical care

program.

(b) The appropriateness of the

proposed program.

(c) Competency of the program

personnel.

(d) Organizational structure, plans for

self-assessment and envisioned

relationship with DOE.

(e) Adequacy of equipment and

associated physical resources.

(f) Reasonableness and

appropriateness of the proposed budget.

In accordance with 10 CFR 602.9(e)

and 10 CFR 600.8(c)(13), a program

policy factor which DOE will consider

in making an award is the merit of an

applicant’s Optional Application for an

alternative approach to the provision of

logistics for primary and secondary

medical care services and the tertiary

medical care services and associated

logistic services as addressed in the

‘‘Specific Application Instructions’’ (see

section VI., B, paragraphs (3) and (4)).

The NIH will conduct the peer review

and score any Optional Application

using the identical procedure for

evaluating the Primary Application.

However, the resulting score will not be

added to the applicant’s score for the

Primary Application, because the merit

of the Optional Application is a program

policy factor. The DOE selecting official

will give the Primary Application

predominant consideration, with lesser

consideration being accorded the

Optional Application.

The resulting award may be for the

Primary Application only, or for the

Primary Application and all or any part

of the Optional Application. An award

will not be made for only an Optional

Application.

One cooperative agreement will be

awarded for the first budget year only

and may be negotiated and extended

annually as continuation awards for up

to four (4) additional years based on the

following:

• Availability of appropriated funds;

• The awardee’s continuation

application, which will be submitted

not later than 120 days before the end

of each budget period, and

• The results of the DOE evaluations

of the awardee’s performance as

described in section VIII., below.

VIII. DOE’s Role

In order for DOE to maintain

appropriate oversight of the special

medical care program, there must be

substantial interaction between DOE

and the awardee. DOE established the

core requirements for this program and

prepared this Notice of Availability of

Funds and Request for Applications.

DOE will conduct the selection and

award process, which will include

evaluations by persons outside the

Federal Government. DOE will utilize

the results of these evaluations and

make one initial award. Continuation

awards may be made based upon the

availability of funds and other DOE

performance criteria that will be set

forth in any initial award. DOE will

consult with program medical

professionals and will coordinate

meetings between medical care

provider(s) and Marshallese community

members. DOE will consult with

representatives from the RMI national

and local governments, the Department

of the Interior, the Department of State

and the Department of Health and

Human Services on the special medical

care program. To help evaluate program

effectiveness, DOE will establish a

program coordination committee as part

of the cooperative agreement consisting

of representatives from the awardee’s

organization, the DOE contracting office,

the DOE Office of International Health

Programs, and the Rongelap and Utirik

communities. This committee will meet

on a semi-annual basis at a mutually

agreed location.
48072 Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices

Finally, DOE will monitor and

evaluate the performance and delivery

of the special medical care program by

conducting program reviews and

considering the patients’ level of

satisfaction.

IX. Applicants

Applicants for the cooperative

agreement could include domestic or

international nonprofit and for profit

organizations, universities, medical

centers, state or local government health

care organizations, labor unions and

other employee representative groups,

small, minority and/or women-owned

businesses, or other domestic or

international health care organizations.

Consortiums of interested organizations

are encouraged to apply. Awardee(s) for

the special medical care program will

work cooperatively with Marshallese

health care providers, current DOE

providers (as applicable), other regional

health care providers and designated

Marshallese community representatives.

Issued in Washington, D.C., on September

8, 1997.

Paul J. Seligman,

Deputy Assistant Secretary for Health Studies.

Appendix A—Definition of Radiation

Related Diseases or Illnesses

For the purposes of this Notice, applicants

shall consider the following to be radiation

related diseases or illnesses:

(a) Any thyroid cancer, other tumor or

thyroid nodule that has been found as a

result of medical evaluation.

(b) In accordance with the ‘‘Radiation

Exposure Compensation Act’’, 42 U.S.C. 2210

note, the following are considered latently

expressed diseases attributed to radiation:

(1) Leukemia (other than chronic

lymphocytic leukemia).

And the following diseases, provided onset

was at least 5 years after the first exposure

to radiation:

(2) Multiple myeloma.

(3) Lymphomas, other than Hodgkin’s

disease.

(4) Primary cancer of the thyroid, provided

that the initial exposure occurred by age 20.

(5) Primary cancer of the female breast,

provided that the initial exposure occurred

prior to age 40.

(6) Primary cancer of the esophagus,

provided low alcohol consumption and not

a heavy smoker.

(7) Primary cancer of the stomach.

(8) Primary cancer of the pharynx,

provided not a heavy smoker.

(9) Primary cancer of the small intestine.

(10) Primary cancer of the pancreas.

(11) Primary cancer of the bile ducts.

(12) Primary cancer of the gall bladder.

(13) Primary cancer of the liver, except if

cirrhosis or hepatitis B is indicated.

Appendix B—RMI Medical Program

Information

Available RMI medical facilities and

services include:

(a) Local dispensaries at Utirik and Mejatto

provide limited medicine and first aid, and

are staffed by medical personnel with

MEDEX level training and experience (i.e.,

between a regional nurse and nursepractitioner). Short-wave radio

communications are maintained between the

dispensaries and the off-island medical

health care providers (up to 300 miles

distant) to discuss serious medical

conditions.

(b) A small 34 bed community hospital is

available with limited capabilities in a

community of 12,000 living on Ebeye (an

island of approximately 4 square miles

located 2 miles from Kwajalein Island where

the U.S. Army contractor-operated hospital

facility that serves the base personnel is

located).

(c) A 75 bed hospital is available with

limited capabilities to serve 29,000 living on

the capital island of Majuro. This hospital

also receives referrals from the entire

national population of 60,000.

Appendix C—The RMI 177 Health Care

Program (HCP)

For the DOE patients:

(a) Currently implements DOE patient care

in absence of Brookhaven National

Laboratory.

(b) Provides all non radiation-related care

of DOE patients.

(c) Provides access to DOE patient records.

For the non-DOE patients:

(a) Provides general medical care for the

people of Rongelap, Utirik, Enewetak, and

Bikini.

(b) Serves a total population of

approximately 10,600 (which includes the

238 DOE patients)

(c) Refers its tertiary patients to the

Queen’s Medical Center and Group in

Honolulu, Hawaii.

Appendix D—Bechtel Nevada Corporation

Logistical Capabilities to Support DOE’S

Special Medical Care Program

(a) Provides all logistics to transport and

support medical program personnel to the

Marshall Islands twice a year, which is

currently limited to travel, lodging and per

diem costs west of Honolulu.

(b) Provides all logistics to transport and

support ambulatory patients and their

authorized medical escorts to medical

facilities at Kwajalein.

(c) Provides all logistics to transport

medical personnel for subsidiary home visits

to non-ambulatory infirm patients at Mejatto,

Ebeye, Utirik, and Majuro.

(d) Provides transportation and support to

RMI medical personnel assigned to

participate in the DOE special medical care

program.

(e) Operates and provides all logistics and

support services for patients referred to the

Straub Hospital and Clinic located in

Honolulu, Hawaii, by Brookhaven National

Laboratory. The services provided include:

(1) Bilingual Marshallese/English speaking

escorts to accompany patients.

(2) Coordination of patient travel and

medical appointment schedules.

(3) Lodging and per diem arrangements

and expenses.

(4) Coordination between Brookhaven

National Laboratory and the Straub Hospital

and Clinic on medical services, as required.

(f) Conducts market research on the

availability of marine assets in the U.S. and

Central Pacific Area to support a limited, seabased medical program.

(g) Issues and monitors the Straub Hospital

and Clinic medical services subcontract.

(h) Implements terms and conditions,

including the making of payments and

collections under DOE’s agreements with

other agencies, and instrumentalities of the

RMI.

(i) Implements requirements as directed by

DOE during the course of the year.

(j) Interfaces and coordinates with the U.S.

Army at Kwajalein Island to provide the

following in accordance with a Memorandum

of Understanding between DOE and the U.S.

Army:

(1) Marine craft (currently a LCU) used to

transport patients to and from Mejatto.

(2) Hospital services as delineated in

Appendix F.

(3) Trailer rentals for medical use

(currently 2, each 660 square feet).

(4) Housing, lodging, and dining facilities

for patients and medical team members.

(5) Maintenance of facilities and

equipment.

(6) Aircraft services limited to within

Kwajalein Atoll at no cost.

(7) Automotive services used to transport

patients at Kwajalein Island.

(8) Recreational services for medical team

use.

(9) Public services used to announce

medical team activities at Kwajalein Atoll.

(10) Ferry services between Kwajalein and

Ebeye Islands at no cost.

Appendix E—Services Provided by the

Straub Hospital and Clinic Located in

Honolulu, Hawaii

(a) Complete and comprehensive medical

services for DOE patients that have radiationrelated diseases, including but not limited to,

nuclear medicine diagnostic imaging and

techniques, diagnostic and radiation therapy

facilities, chemotherapy, pathological and

advanced surgical services.

(b) Refers diseases diagnosed as non

radiation-related back to the 177 HCP.

(c) Provides certified and accredited

medical personnel.

(d) Provides price list as basis for charges.

Note: Straub Hospital and Clinic is

accredited by the Joint Commission for

Accreditation of Health Care Organizations.

Appendix F—Secondary Medical Services

Provided by U.S. Army Hospital on

Kwajalein Island in the Kwajalein Atoll in

the RMI

In accordance with the Memorandum of

Understanding between DOE and the U.S.

Army, the following medical services are

provided at the U.S. Army Hospital on

Kwajalein Island:

(a) Laboratory Services.

(b) Mammography Screening.

(c) X-ray Screening.

(d) Proctosigmoidoscopy.

(e) Limited Surgery (e.g., appendectomy,

amputations for advanced diabetic

conditions).
Federal Register / Vol. 62, No. 177 / Friday, September 12, 1997 / Notices 48073

(f) Professional Services (physicians,

nurses, technicians).

(g) Safety inspection and certification of

mammography and x-ray equipment by

Trippler Army Hospital technical staff.

(h) Inpatient care and treatment.

Note: Brookhaven National Laboratory is

responsible to ensure that proper and current

certification for the special medical

equipment and services are in place prior to

receiving services.

Appendix G—DOE Special Medical Program

Information

1. Summary of Clinical Findings

After 41 years of medical monitoring, the

most prevalent health effect has been related

to thyroid function and the appearance of

thyroid-related nodules and cancer. There

has been one case and death due to radiationrelated leukemia, two pituitary tumors and

two cases of basal cell carcinoma. The major

non radiation-related diseases seen in the

Rongelap and Utirik people have been Type

II diabetes, hypertension, cardiovascular

diseases, and their associated complications.

The above information has been

summarized from the report entitled,

‘‘Medical Status of Marshallese Accidentally

Exposed to 1954 Bravo Fallout Radiation;

January 1988 Through December 1991,’’ by

Brookhaven National Laboratory/Department

of Energy, DOE/EH0493 and BNL–52470,

July 1995.

2. Patient Population Description

Age range Male Female

30–39 ................................ 1 1

40–49 ................................ 57 59

50–59 ................................ 28 35

60–69 ................................ 15 19

70–79 ................................ 8 12

80+ .................................... 1 2

3. Summary of Patient Location

Patients in the Rongelap and Utirik

populations are combined in the table below

and represent approximate estimates of total

patients in each location:

Location Female Male Total

Ailinglaplap ........ 1 1 2

Ailingnae ............ 2 0 2

Arno ................... 1 0 1

Ebeye ................ 40 33 73

Hawaii ................ 9 4 13

Kili ...................... 1 0 1

Lib ...................... 1 0 1

Mainland USA ... 4 2 6

Majuro ............... 41 46 87

Mejatto ............... 19 12 31

Mejit ................... 1 1 2

Ujae ................... 1 1 2

Unknown ........... 1 0 1

Utirik .................. 6 8 14

Wotje ................. 1 1 2

Total ........... 129 109 238

Appendix H—DOE Equipment Used by

Brookhaven National Laboratory

(a) Johnson & Johnson

Ektachem DT60 II-DTSC II Module Chemistry

Analyzer

K-Number 339 4116, Serial Number

60029378

(b) Kodak-Ektachem DT60 DTSC Module

Chemistry Analyzer

K-Number 337 0137

(c) Ektachem DT60 Module Chemistry

Analyzer

K-Number 322 1695

(d) Calposcope

(e) Ultramark 4 Plus with transducers

(f) Nikon Microscope

(g) Sereno Baker 9118c Blood Analyzer

Machine

(h) Ektachem DT60II System

(i) Biorad Micromat Model 415

(j) Beckman TJ6 Centrifuge

(k) Portable defibrillator

(l) Hoag-Streit Slip Lamp system

(m) Sun computer workstation

[FR Doc. 97–24225 Filed 9–11–97; 8:45 am]

BILLING CODE 6450–01–P

DEPARTMENT OF ENERGY

Inventions Available for License

AGENCY: Department of Energy, Office of

General Counsel.

ACTION: Notice.

SUMMARY: The U.S. Department of

Energy announces that the following

invention is available for license in

accordance with 35 U.S.C. 207–209.

Israel Patent Application S.N. 119,342,

entitled ‘‘Methods for Priming and DNA

Sequencing,’’ and corresponding patent

applications, to be filed in the U.S.A. and

other countries.

FOR FURTHER INFORMATION CONTACT:

Robert J. Marchick, Office of the

Assistant General Counsel for

Technology Transfer and Intellectual

Property, U.S. Department of Energy,

1000 Independence Avenue, S.W.,

Washington, D.C. 20585; Telephone

(202) 586–2802.

SUPPLEMENTARY INFORMATION: 35 U.S.C.

207 authorizes licensing of Governmentowned inventions. Implementing

regulations are contained in 37 CFR part

404. 37 CFR 404.7(a)(1) authorizes

exclusive licensing of Governmentowned inventions under certain

circumstances, provided that notice of

the invention’s availability for license

has been announced in the Federal

Register.

* Issued in Washington, D.C., on

September 5, 1997.

Paul A. Gottlieb,

Assistant General Counsel for Technology

Transfer and Intellectual Property.

[FR Doc. 97–24221 Filed 9–11–97; 8:45 am]

BILLING CODE 6450–01–P

DEPARTMENT OF ENERGY

Environmental Management Advisory

Board

AGENCY: Department of Energy.

ACTION: Notice of open meeting.

SUMMARY: Pursuant to the provisions of

the Federal Advisory Committee Act

(Public Law 92–463, 86 Stat. 770),

notice is hereby given of the following

Advisory Committee meeting:

Name: Environmental Management

Advisory Board.

Date and Times: Wednesday, October

1, 1997, 8:30 a.m.–3:00 p.m.

Place: U.S. Department of Energy/

Forrestal Building, 1000 Independence

Avenue, S.W.; Room 1E–245,

Washington, D.C. 20585.

FOR FURTHER INFORMATION CONTACT:

James T. Melillo, Special Assistant to

the Assistant Secretary for

Environmental Management;

Environmental Management Advisory

Board (EMAB), EM–22, 1000

Independence Avenue, S.W.,

Washington, DC 20585, (202) 586–4400.

The Internet address is:

James.Melillo@em.doe.gov

SUPPLEMENTARY INFORMATION:

Purpose of the Board

The purpose of the Board is to

provide the Assistant Secretary for

Environmental Management (EM) with

advice and recommendations on issues

confronting the Environmental

Management program from the

perspectives of affected groups and

state, local, and tribal governments. The

Board will help to improve the

Environmental Management Program by

assisting in the process of securing

consensus recommendations, and

providing the Department’s numerous

publics with opportunities to express

their opinions regarding the

Environmental Management Program.

Tentative Agenda

Wednesday, October 1, 1997

8:30 a.m. Co-Chairmen Open Public

Meeting

8:45 a.m. Opening Remarks, Assistant

Secretary for Environmental

Management

9:00 a.m. Baseline Project Presentation

9:30 a.m. Technology Development and

Transfer Committee Presentation and

Discussion

10:00 a.m. 2006 Plan & Strategic

Integration Committees Presentation

and Discussion

10:30 a.m. Privatization Committee

Presentation and Discussion

11:00 a.m. Science Committee

Presentation and Discussion